Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 17, 2001

View Archived Issues

Biotech Industry Backs Patent Ruling; Parliament Reticent

Language Gene Hailed As Cognitive Genetics Landmark

French Biotech Industry Calls For US$3.6B In State Support

Switch Biotech Raises EUR18M, Moves Focus To Development

Hybrigenics, Institut Pasteur Extend Proteomics Alliance

Huntingdon Life Moving To U.S. Market Due To Activism

Xenovas Genital Herpes Trial Fails; Glaxo Opts Out Of Deal

CAT Enters First Collaboration In Area Of Infectious Disease

Genmab Enters Development Deals With Immunex, Scancell

Other News To Note

Proteome Scinces Completes US$7M Funding Of Subsidiary

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...